Key Findings
Professor Junji Fukuda and his team at Yokohama National University have established a method to mass-produce hair papilla cells from approximately 10 hairs harvested from a patient’s occipital region. The core breakthrough is a “multi-layer culture” technique that overcomes the traditional loss of hair-inducing function associated with standard planar cell expansion. When combined with a specialized animal-free medium developed with Rohto Pharmaceutical, the expression of the hair-growth-related gene alkaline phosphatase (ALP) increased 100-fold.
Technical Details
The research focuses on the hair papilla cells, which act as the control center for the hair cycle via Wnt and TGF-β signals. Fukuda’s team compared several cultivation methods:
- Planar Culture: Cells increased in number but showed a significant drop in ALP expression.
- Spheroid Culture: Maintained hair-inducing functions better than planar culture, but cell counts did not increase sufficiently for medical application.
- Multi-layer Culture: By continuing cultivation beyond the confluent stage (approximately 5 days), cells formed 3–5 layer thick clusters. After 30 days, cell counts increased approximately 20-fold, and ALP expression reached approximately 7 times the initial level.
To ensure clinical safety, the team transitioned from fetal bovine serum (FBS) to animal-free media. Using a commercially available Rohto Pharmaceutical medium doubled cell proliferation and increased ALP expression 30-fold; a further joint development of a new medium increased ALP expression 100-fold.
Background and Context
Fukuda, who previously worked on artificial liver development, pivoted to hair regeneration due to lower costs and higher scalability. The team is pursuing three therapeutic approaches: activating dormant follicles via mesenchymal cell transplantation, transplanting hair follicle primordia, and transplanting hair follicle organoids for end-stage alopecia.
Significance and Outlook
The multi-layer culture method is the most viable for immediate application due to its simplicity. Fukuda has established a venture company to move toward clinical trials for hair papilla cell transplantation. Additionally, the team has successfully created human hair follicle organoids in vitro, which are now being developed as a quantitative evaluation system for testing the efficacy of hair growth agents like minoxidil.
Get our weekly technology intelligence — free
Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.
Subscribe Free — Weekly Tech Intelligence
By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.
- Your email and selected fields are used only to deliver the newsletter.
- We never share your information with third parties.
- You can unsubscribe anytime via the link in each email.
See our Privacy Policy for details.
Takes about a minute · Unsubscribe anytime



